1. Home
  2. GETY vs ARDX Comparison

GETY vs ARDX Comparison

Compare GETY & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GETY
  • ARDX
  • Stock Information
  • Founded
  • GETY 1995
  • ARDX 2007
  • Country
  • GETY United States
  • ARDX United States
  • Employees
  • GETY N/A
  • ARDX N/A
  • Industry
  • GETY Industrial Machinery/Components
  • ARDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GETY Industrials
  • ARDX Health Care
  • Exchange
  • GETY Nasdaq
  • ARDX Nasdaq
  • Market Cap
  • GETY 867.0M
  • ARDX 882.9M
  • IPO Year
  • GETY N/A
  • ARDX 2014
  • Fundamental
  • Price
  • GETY $2.11
  • ARDX $5.04
  • Analyst Decision
  • GETY Hold
  • ARDX Strong Buy
  • Analyst Count
  • GETY 6
  • ARDX 9
  • Target Price
  • GETY $4.76
  • ARDX $10.50
  • AVG Volume (30 Days)
  • GETY 800.4K
  • ARDX 3.2M
  • Earning Date
  • GETY 11-10-2025
  • ARDX 10-30-2025
  • Dividend Yield
  • GETY N/A
  • ARDX N/A
  • EPS Growth
  • GETY N/A
  • ARDX N/A
  • EPS
  • GETY N/A
  • ARDX N/A
  • Revenue
  • GETY $946,828,000.00
  • ARDX $386,146,000.00
  • Revenue This Year
  • GETY $2.35
  • ARDX $17.42
  • Revenue Next Year
  • GETY $3.07
  • ARDX $26.90
  • P/E Ratio
  • GETY N/A
  • ARDX N/A
  • Revenue Growth
  • GETY 4.43
  • ARDX 83.88
  • 52 Week Low
  • GETY $1.25
  • ARDX $3.21
  • 52 Week High
  • GETY $4.49
  • ARDX $6.78
  • Technical
  • Relative Strength Index (RSI)
  • GETY 50.46
  • ARDX 39.69
  • Support Level
  • GETY $2.02
  • ARDX $5.04
  • Resistance Level
  • GETY $2.22
  • ARDX $5.18
  • Average True Range (ATR)
  • GETY 0.15
  • ARDX 0.18
  • MACD
  • GETY -0.01
  • ARDX 0.02
  • Stochastic Oscillator
  • GETY 39.22
  • ARDX 54.75

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: